首页 > 最新文献

BMJ Open最新文献

英文 中文
Nutritional knowledge, attitudes and practices and their determinants among pregnant women attending healthcare centres in southern Tehran. 在德黑兰南部保健中心就诊的孕妇的营养知识、态度和做法及其决定因素。
IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-14 DOI: 10.1136/bmjopen-2025-102117
Golnaz Rajaeieh, Ahad Bakhtiari, Masoomeh Gholami, Fatemeh Ghavidel, Hakimeh Mostafavi, Mitra Zabihi, Efat Mohamadi, Alireza Olyaeemanesh, Amirhossein Takian

Objectives: To assess nutrition-related knowledge, attitudes and practices among pregnant women, and identify socioeconomic and healthcare determinants.

Design: A cross-sectional study on maternal nutrition during pregnancy.

Setting: Pregnant women attending primary healthcare centres in the south of Tehran from December 2022 to March 2024.

Participants: 1535 pregnant women of all ages living in the south of Tehran (both Iranian and non-Iranian).

Measures: Pregnant women were systematically selected from primary healthcare centres. Data were collected via validated questionnaires and electronic health records. Statistical analyses included multivariate logistic regression (adjusted ORs (aORs) with 95% CIs) and generalised linear mixed models.

Results: The findings revealed that a majority of pregnant women (83.3%; 95% CI 81.2% to 85.3%) exhibited low levels of nutritional knowledge (scores below 12), whereas 14% demonstrated moderate knowledge (scores between 12 and 17), and only 2.7% (95% CI 1.9% to 3.8%) possessed high nutritional knowledge (scores above 18). In terms of attitudes, 36.9% of respondents expressed positive views toward nutrition, with higher education significantly associated with positive attitudes (aOR=1.8; 95% CI 1.3 to 2.5, comparing higher vs lower education levels). Dietary variety was consistently reported by 65.4% of participants, while 8.5% lacked dietary variety. Statistically significant associations were observed between educational attainment, socioeconomic status and nutrition-related practices (p<0.05). Women with a university-level education achieved knowledge scores 3.2 times greater (95% CI 2.1 to 4.9) than those with only primary education. Moreover, individuals in the highest wealth quintile demonstrated practices that were 2.1 times superior (95% CI 1.5 to 3.0) to those in the lowest quintile. Nutritional counselling by professionals was positively correlated with improved attitudes (aOR=2.4; 95% CI 1.7 to 3.4).

Conclusion: As a cross-sectional study, these findings highlight substantial gaps in nutrition knowledge among pregnant women in Tehran, with socioeconomic status and education playing crucial roles in shaping dietary behaviours. Improving nutritional education through healthcare interventions is essential for enhancing maternal and fetal health outcomes.

目的:评估孕妇的营养相关知识、态度和做法,并确定社会经济和保健决定因素。设计:一项关于孕期产妇营养的横断面研究。环境:2022年12月至2024年3月期间在德黑兰南部初级保健中心就诊的孕妇。参与者:1535名居住在德黑兰南部的所有年龄段的孕妇(包括伊朗人和非伊朗人)。措施:系统地从初级保健中心挑选孕妇。通过有效的问卷调查和电子健康记录收集数据。统计分析包括多元逻辑回归(调整后的or (aORs) 95% ci)和广义线性混合模型。结果:调查结果显示,大多数孕妇(83.3%;95% CI 81.2%至85.3%)表现出低水平的营养知识(得分低于12),而14%表现出中等知识(得分在12至17之间),只有2.7% (95% CI 1.9%至3.8%)具有高营养知识(得分高于18)。在态度方面,36.9%的受访者对营养持积极态度,高学历与积极态度显著相关(aOR=1.8; 95% CI 1.3至2.5,比较高学历与低学历)。65.4%的参与者一致报告饮食多样性,而8.5%的参与者缺乏饮食多样性。结论:作为一项横断面研究,这些发现突出了德黑兰孕妇在营养知识方面的巨大差距,社会经济地位和教育在塑造饮食行为方面发挥着关键作用。通过保健干预措施改善营养教育对改善孕产妇和胎儿健康结果至关重要。
{"title":"Nutritional knowledge, attitudes and practices and their determinants among pregnant women attending healthcare centres in southern Tehran.","authors":"Golnaz Rajaeieh, Ahad Bakhtiari, Masoomeh Gholami, Fatemeh Ghavidel, Hakimeh Mostafavi, Mitra Zabihi, Efat Mohamadi, Alireza Olyaeemanesh, Amirhossein Takian","doi":"10.1136/bmjopen-2025-102117","DOIUrl":"https://doi.org/10.1136/bmjopen-2025-102117","url":null,"abstract":"<p><strong>Objectives: </strong>To assess nutrition-related knowledge, attitudes and practices among pregnant women, and identify socioeconomic and healthcare determinants.</p><p><strong>Design: </strong>A cross-sectional study on maternal nutrition during pregnancy.</p><p><strong>Setting: </strong>Pregnant women attending primary healthcare centres in the south of Tehran from December 2022 to March 2024.</p><p><strong>Participants: </strong>1535 pregnant women of all ages living in the south of Tehran (both Iranian and non-Iranian).</p><p><strong>Measures: </strong>Pregnant women were systematically selected from primary healthcare centres. Data were collected via validated questionnaires and electronic health records. Statistical analyses included multivariate logistic regression (adjusted ORs (aORs) with 95% CIs) and generalised linear mixed models.</p><p><strong>Results: </strong>The findings revealed that a majority of pregnant women (83.3%; 95% CI 81.2% to 85.3%) exhibited low levels of nutritional knowledge (scores below 12), whereas 14% demonstrated moderate knowledge (scores between 12 and 17), and only 2.7% (95% CI 1.9% to 3.8%) possessed high nutritional knowledge (scores above 18). In terms of attitudes, 36.9% of respondents expressed positive views toward nutrition, with higher education significantly associated with positive attitudes (aOR=1.8; 95% CI 1.3 to 2.5, comparing higher vs lower education levels). Dietary variety was consistently reported by 65.4% of participants, while 8.5% lacked dietary variety. Statistically significant associations were observed between educational attainment, socioeconomic status and nutrition-related practices (p<0.05). Women with a university-level education achieved knowledge scores 3.2 times greater (95% CI 2.1 to 4.9) than those with only primary education. Moreover, individuals in the highest wealth quintile demonstrated practices that were 2.1 times superior (95% CI 1.5 to 3.0) to those in the lowest quintile. Nutritional counselling by professionals was positively correlated with improved attitudes (aOR=2.4; 95% CI 1.7 to 3.4).</p><p><strong>Conclusion: </strong>As a cross-sectional study, these findings highlight substantial gaps in nutrition knowledge among pregnant women in Tehran, with socioeconomic status and education playing crucial roles in shaping dietary behaviours. Improving nutritional education through healthcare interventions is essential for enhancing maternal and fetal health outcomes.</p>","PeriodicalId":9158,"journal":{"name":"BMJ Open","volume":"16 1","pages":"e102117"},"PeriodicalIF":2.3,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145984408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trajectory, healthcare utilisation and recovery in 3590 individuals with long covid: a 4-year prospective cohort analysis. 3590名长冠患者的轨迹、医疗保健利用和康复:一项4年前瞻性队列分析
IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-14 DOI: 10.1136/bmjopen-2025-103884
Jai Prashar, Toby Hillman, Emma C Wall, Amanpreet Sarna, Emma Mi, Robert Bell, Jagdeep Sahota, Michael Zandi, Patricia McNamara, Rebecca Livingston, Rebecca Gore, Catherine Lunken, Elena Bax, Rachel Nyam, Amir Masood Rafie Manzelat, Lyth Hishmeh, Emily Attree, Stephen Cone, Amitava Banerjee, Melissa Heightman

Objective: To characterise long-term trajectory of recovery in individuals with long covid.

Design: Prospective cohort.

Setting: Single-centre, specialist post-COVID service (London, UK).

Participants: Individuals aged ≥18 years with long covid (hospitalised and non-hospitalised) from April 2020 to March 2024.

Main outcome measures: Routine, prospectively collected data on symptoms, quality of life (including Fatigue Assessment Scale (FAS) and EuroQol 5 Dimensions (EQ-5D), return to work status and healthcare utilisation (investigations, outpatient and emergency attendances). The primary outcome was recovery by self-reported >75% of 'best health' (EQ-5D Visual Analogue Scale) and was assessed using Cox proportional hazards regression models over 4 years. Linked National Health Service England registry data provided secondary care healthcare utilisation and expenditure.

Results: We included 3590 individuals (63.3% female, 73.5% non-hospitalised, median age 50.0 years, 71.9% with ≥2 doses of COVID-19 vaccination), who were followed up for a median of 136 (0-346) days since first assessment and 502 (251-825) days since symptom onset. At first assessment, 33.2% of employed individuals were unable to work. Dominant symptoms were fatigue (78.7%), breathlessness (68.1%) and brain fog (53.5%). 33.4% of individuals recovered to >75% of best health prior to clinic discharge (recovery occurred median 202 (94-468) days from symptom onset). Vaccinated individuals were more likely to recover faster (pre: HR 2.93 (2.00-4.28) and post: HR 1.34 (1.05-1.71) COVID-19 infection), whereas recovery hazard was inversely associated with FAS (HR 0.37 (0.33-0.42)), myalgia (HR 0.59 (0.45-0.76)) and dysautonomic symptoms (HR 0.46 (0.34-0.62)). There was high secondary care healthcare utilisation (both emergency and outpatient care). Annual inpatient and outpatient expenditure was significantly lower in hospitalised individuals while under the service. When compared with the prereferral period, emergency department attendances were reduced in non-hospitalised patients with long covid, but outpatient costs increased.

Conclusions: In the largest long covid cohort from a single specialist post-COVID service to date, only one-third of individuals under follow-up achieved satisfactory recovery. Fatigue severity and COVID-19 vaccination at presentation, even after initial COVID-19 infection, was associated with long covid recovery. Ongoing service provision for this and other post-viral conditions is necessary to support care, progress treatment options and provide capacity for future pandemic preparedness. Research and clinical services should emphasise these factors as the strongest predictors of non-recovery.

目的:了解长冠肺炎患者的长期康复轨迹。设计:前瞻性队列。环境:单中心、专业的疫情后服务(英国伦敦)。参与者:2020年4月至2024年3月期间年龄≥18岁的长冠患者(住院和非住院)。主要结果测量:常规、前瞻性收集的症状、生活质量(包括疲劳评估量表(FAS)和EuroQol 5维度(EQ-5D)、重返工作状态和医疗保健利用(调查、门诊和急诊)数据。主要终点是自我报告的“最佳健康”(EQ-5D视觉模拟量表)恢复为bb0 - 75%,并使用Cox比例风险回归模型在4年内进行评估。英国国民健康服务注册数据提供了二级医疗保健的利用和支出。结果:我们纳入了3590例患者(63.3%为女性,73.5%未住院,中位年龄50.0岁,71.9%接种了≥2剂COVID-19疫苗),自首次评估以来的中位随访时间为136(0-346)天,自症状出现以来的中位随访时间为502(251-825)天。在第一次评估中,33.2%的就业人员无法工作。主要症状为疲劳(78.7%)、呼吸困难(68.1%)和脑雾(53.5%)。33.4%的个体在出院前恢复至最佳健康状态的75%(从症状出现后中位数为202(94-468)天)。接种疫苗的个体更有可能恢复得更快(感染COVID-19前:HR 2.93(2.00-4.28)和后:HR 1.34(1.05-1.71),而恢复风险与FAS (HR 0.37(0.33-0.42))、肌痛(HR 0.59(0.45-0.76))和自主神经异常症状(HR 0.46(0.34-0.62))呈负相关。二级医疗保健的使用率很高(包括急诊和门诊)。接受这项服务的住院个人的年度住院和门诊费用明显较低。与预诊期相比,非住院长covid患者的急诊就诊人数减少,但门诊费用增加。结论:在迄今为止来自单一专业covid后服务的最大长期covid队列中,只有三分之一的随访个体实现了令人满意的恢复。疲劳严重程度和covid -19疫苗接种与covid -19长期康复有关,即使是在最初感染covid -19之后。必须持续为这种情况和其他病毒后情况提供服务,以支持护理、改进治疗方案并为今后的大流行病防范提供能力。研究和临床服务应强调这些因素是无法康复的最强预测因素。
{"title":"Trajectory, healthcare utilisation and recovery in 3590 individuals with long covid: a 4-year prospective cohort analysis.","authors":"Jai Prashar, Toby Hillman, Emma C Wall, Amanpreet Sarna, Emma Mi, Robert Bell, Jagdeep Sahota, Michael Zandi, Patricia McNamara, Rebecca Livingston, Rebecca Gore, Catherine Lunken, Elena Bax, Rachel Nyam, Amir Masood Rafie Manzelat, Lyth Hishmeh, Emily Attree, Stephen Cone, Amitava Banerjee, Melissa Heightman","doi":"10.1136/bmjopen-2025-103884","DOIUrl":"https://doi.org/10.1136/bmjopen-2025-103884","url":null,"abstract":"<p><strong>Objective: </strong>To characterise long-term trajectory of recovery in individuals with long covid.</p><p><strong>Design: </strong>Prospective cohort.</p><p><strong>Setting: </strong>Single-centre, specialist post-COVID service (London, UK).</p><p><strong>Participants: </strong>Individuals aged ≥18 years with long covid (hospitalised and non-hospitalised) from April 2020 to March 2024.</p><p><strong>Main outcome measures: </strong>Routine, prospectively collected data on symptoms, quality of life (including Fatigue Assessment Scale (FAS) and EuroQol 5 Dimensions (EQ-5D), return to work status and healthcare utilisation (investigations, outpatient and emergency attendances). The primary outcome was recovery by self-reported >75% of 'best health' (EQ-5D Visual Analogue Scale) and was assessed using Cox proportional hazards regression models over 4 years. Linked National Health Service England registry data provided secondary care healthcare utilisation and expenditure.</p><p><strong>Results: </strong>We included 3590 individuals (63.3% female, 73.5% non-hospitalised, median age 50.0 years, 71.9% with ≥2 doses of COVID-19 vaccination), who were followed up for a median of 136 (0-346) days since first assessment and 502 (251-825) days since symptom onset. At first assessment, 33.2% of employed individuals were unable to work. Dominant symptoms were fatigue (78.7%), breathlessness (68.1%) and brain fog (53.5%). 33.4% of individuals recovered to >75% of best health prior to clinic discharge (recovery occurred median 202 (94-468) days from symptom onset). Vaccinated individuals were more likely to recover faster (pre: HR 2.93 (2.00-4.28) and post: HR 1.34 (1.05-1.71) COVID-19 infection), whereas recovery hazard was inversely associated with FAS (HR 0.37 (0.33-0.42)), myalgia (HR 0.59 (0.45-0.76)) and dysautonomic symptoms (HR 0.46 (0.34-0.62)). There was high secondary care healthcare utilisation (both emergency and outpatient care). Annual inpatient and outpatient expenditure was significantly lower in hospitalised individuals while under the service. When compared with the prereferral period, emergency department attendances were reduced in non-hospitalised patients with long covid, but outpatient costs increased.</p><p><strong>Conclusions: </strong>In the largest long covid cohort from a single specialist post-COVID service to date, only one-third of individuals under follow-up achieved satisfactory recovery. Fatigue severity and COVID-19 vaccination at presentation, even after initial COVID-19 infection, was associated with long covid recovery. Ongoing service provision for this and other post-viral conditions is necessary to support care, progress treatment options and provide capacity for future pandemic preparedness. Research and clinical services should emphasise these factors as the strongest predictors of non-recovery.</p>","PeriodicalId":9158,"journal":{"name":"BMJ Open","volume":"16 1","pages":"e103884"},"PeriodicalIF":2.3,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145984425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The journey to healing: exploring travel challenges and associated costs for cancer care at a tertiary care centre in Puducherry, Southern India - a mixed methods study. 治疗之旅:在印度南部普杜切里的一个三级医疗中心探索癌症治疗的旅行挑战和相关费用——一项混合方法研究。
IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-13 DOI: 10.1136/bmjopen-2025-104210
Loganathan Devaraj, Reshma Ayiraveetil, Kalaiselvy Arikrishnan, Swaroop Kumar Sahu, Prasanth Ganesan, Gunaseelan Karunanithi, Sona Priyanka Auroprem, Tamil Selvan Srinivasan, Mahalakshmy Thulasingam

Objectives: This study aims to assess travel time, associated costs, challenges and factors influencing healthcare facility choices among persons with cancer in Southern India.

Design: An explanatory sequential mixed methods study.

Setting: The study was conducted in the cancer care outpatient department at a tertiary care centre in Puducherry, Southern India.

Participants: A total of 192 persons with cancer aged 18 to 65 years, diagnosed with breast, lip and oral cavity, cervical, lung or upper gastrointestinal cancers, and attending the cancer care centre between 2023 and 2024, were enrolled in the study through systematic random sampling. Additionally, 10 in-depth interviews were conducted using purposive sampling.

Results: Of the 192 participants, 89 (46.4%) belonged to a lower socioeconomic group, and 178 (92.7%) reported experiencing financial hardship while undergoing cancer treatment. The median travel time to a tertiary care centre was 4.3 hours (IQR: 2.07-7.3), with a median direct non-medical cost of Indian Rupees (INR) 453 (IQR: 200-987). Median expenditures for travel, food and accommodation were INR 200 (IQR: 123-400), INR 360 (IQR: 150-613) and INR 30 (IQR: 20-60), respectively, per single visit. A significant proportion of participants (n=146, 76%) were unaware of nearby cancer treatment centres and relied on peer recommendations when choosing their place of treatment. Key challenges identified included long-distance travel, financial burden due to high food and transportation costs and limited affordability for accommodation.

Conclusion: The study highlights that prolonged travel time and associated costs pose substantial financial strain on cancer-affected families. Enhancing awareness of available healthcare facilities, implementing patient-friendly travel and accommodation support systems and decentralising cancer care services can improve accessibility and mitigate both travel and financial burdens.

目的:本研究旨在评估印度南部癌症患者的出行时间、相关成本、挑战和影响医疗机构选择的因素。设计:解释性顺序混合方法研究。环境:该研究在印度南部普杜切里的一家三级医疗中心的癌症护理门诊部进行。参与者:通过系统随机抽样,共有192名年龄在18至65岁之间的癌症患者,他们被诊断患有乳腺癌、唇部和口腔癌、宫颈癌、肺癌或上胃肠道癌,并在2023年至2024年期间在癌症护理中心就诊。此外,采用有目的抽样进行了10次深度访谈。结果:在192名参与者中,89名(46.4%)属于较低的社会经济群体,178名(92.7%)报告在接受癌症治疗期间经历了经济困难。前往三级保健中心的路途时间中位数为4.3小时(IQR: 2.07-7.3),直接非医疗费用中位数为印度卢比(INR) 453 (IQR: 200-987)。每次访问的旅行、饮食和住宿支出中位数分别为200卢比(IQR: 123-400)、360卢比(IQR: 150-613)和30卢比(IQR: 20-60)。相当大比例的参与者(n=146, 76%)不知道附近的癌症治疗中心,在选择治疗地点时依赖于同行的推荐。确定的主要挑战包括长途旅行、高昂的食品和运输费用造成的财政负担以及有限的住宿负担能力。结论:该研究强调,长时间的旅行和相关费用给癌症患者家庭带来了巨大的经济压力。提高对现有卫生保健设施的认识,实施对患者友好的旅行和住宿支持系统,以及分散癌症护理服务,可以改善可及性,减轻旅行和经济负担。
{"title":"The journey to healing: exploring travel challenges and associated costs for cancer care at a tertiary care centre in Puducherry, Southern India - a mixed methods study.","authors":"Loganathan Devaraj, Reshma Ayiraveetil, Kalaiselvy Arikrishnan, Swaroop Kumar Sahu, Prasanth Ganesan, Gunaseelan Karunanithi, Sona Priyanka Auroprem, Tamil Selvan Srinivasan, Mahalakshmy Thulasingam","doi":"10.1136/bmjopen-2025-104210","DOIUrl":"https://doi.org/10.1136/bmjopen-2025-104210","url":null,"abstract":"<p><strong>Objectives: </strong>This study aims to assess travel time, associated costs, challenges and factors influencing healthcare facility choices among persons with cancer in Southern India.</p><p><strong>Design: </strong>An explanatory sequential mixed methods study.</p><p><strong>Setting: </strong>The study was conducted in the cancer care outpatient department at a tertiary care centre in Puducherry, Southern India.</p><p><strong>Participants: </strong>A total of 192 persons with cancer aged 18 to 65 years, diagnosed with breast, lip and oral cavity, cervical, lung or upper gastrointestinal cancers, and attending the cancer care centre between 2023 and 2024, were enrolled in the study through systematic random sampling. Additionally, 10 in-depth interviews were conducted using purposive sampling.</p><p><strong>Results: </strong>Of the 192 participants, 89 (46.4%) belonged to a lower socioeconomic group, and 178 (92.7%) reported experiencing financial hardship while undergoing cancer treatment. The median travel time to a tertiary care centre was 4.3 hours (IQR: 2.07-7.3), with a median direct non-medical cost of Indian Rupees (INR) 453 (IQR: 200-987). Median expenditures for travel, food and accommodation were INR 200 (IQR: 123-400), INR 360 (IQR: 150-613) and INR 30 (IQR: 20-60), respectively, per single visit. A significant proportion of participants (n=146, 76%) were unaware of nearby cancer treatment centres and relied on peer recommendations when choosing their place of treatment. Key challenges identified included long-distance travel, financial burden due to high food and transportation costs and limited affordability for accommodation.</p><p><strong>Conclusion: </strong>The study highlights that prolonged travel time and associated costs pose substantial financial strain on cancer-affected families. Enhancing awareness of available healthcare facilities, implementing patient-friendly travel and accommodation support systems and decentralising cancer care services can improve accessibility and mitigate both travel and financial burdens.</p>","PeriodicalId":9158,"journal":{"name":"BMJ Open","volume":"16 1","pages":"e104210"},"PeriodicalIF":2.3,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145964995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the effect of transcranial magnetic stimulation combined with active sensory training on upper limb motor recovery after stroke: protocol for a randomised, sham-controlled, single-centre trial. 研究经颅磁刺激联合主动感觉训练对中风后上肢运动恢复的影响:一项随机、假对照、单中心试验方案
IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-13 DOI: 10.1136/bmjopen-2025-102372
Yichen Jiang, Guangyue Zhu, Congcong Huo, Jinglei Wu, Wenxi Li, Mengchai Mao, Fan Hu, Jiayi Xia, Dongsheng Xu

Introduction: Transcranial magnetic stimulation (TMS) and upper extremity manipulation training have demonstrated clinical effectiveness in stroke rehabilitation. Post-stroke, the affected cerebral cortex often shows reduced excitability, which can limit the optimal outcomes of conventional manual training. To address this, we developed a new upper limb training method integrating TMS with active sensory training (AST) to enhance the fine motor ability in the upper limbs following stroke, potentially improving overall rehabilitation efficacy. However, the clinical effectiveness of this approach remains unclear. Importantly, we demonstrated the efficacy of the new rehabilitation strategy by using TMS in conjunction with AST in patients experiencing upper limb motor dysfunction after stroke.

Methods and analysis: This single-centre, single-blind, sham stimulation, randomised controlled clinical trial investigated the efficacy of AST combined with TMS in patients with stroke and upper limb motor dysfunction post-stroke (1-24 months post-onset) at Brunnstrom stages III-V. Upper limb motor function was evaluated before and 2 weeks after the intervention. The primary outcome was the Action Research Arm Test result, and the secondary indicators included results on the Fugl-Meyer Assessment Upper Extremity Scale, Modified Barthel Index, Semmes-Weinstein Monofilament, Erasmus MC revised Nottingham Sensory Assessment Scale, Embodied Sense of Self Scale (stroke version), functional near-infrared spectroscopy and neuroelectrophysiology. Between-group differences were analysed using independent t-tests, and within-group differences were examined with paired t-tests, with statistical significance set at p<0.05.

Ethics and dissemination: This study was approved by the Ethics Committee of the Second Rehabilitation Hospital of Shanghai for ethical application (Approval number: 2024-34-01). Written informed consent will be obtained from all participants. Study results will be disseminated through peer-reviewed journals and presentations at local and international conferences.

Trial registration number: ChiCTR2500097067.

经颅磁刺激(TMS)和上肢操作训练在脑卒中康复中的临床效果已得到证实。中风后,受影响的大脑皮层通常表现出兴奋性降低,这可能限制传统手工训练的最佳效果。为了解决这个问题,我们开发了一种新的上肢训练方法,将经颅磁刺激与主动感觉训练(AST)相结合,以增强中风后上肢的精细运动能力,从而有可能提高整体康复效果。然而,这种方法的临床效果尚不清楚。重要的是,我们通过使用经颅磁刺激联合AST治疗中风后上肢运动功能障碍的患者,证明了这种新的康复策略的有效性。方法与分析:这项单中心、单盲、假刺激、随机对照临床试验研究了AST联合TMS治疗脑卒中后上肢运动功能障碍患者(发病后1-24个月)在Brunnstrom III-V期的疗效。在干预前和干预后2周评估上肢运动功能。主要指标为动作研究臂测试结果,次要指标为Fugl-Meyer上肢评估量表、修正Barthel指数、Semmes-Weinstein单丝、Erasmus MC修正Nottingham感觉评估量表、体现自我感量表(中风版)、功能近红外光谱和神经电生理结果。组间差异采用独立t检验,组内差异采用配对t检验,在伦理与传播方面具有统计学意义。本研究经上海市第二康复医院伦理委员会伦理申请批准(批准号:2024-34-01)。所有参与者均需获得书面知情同意。研究结果将通过同行评议的期刊和在当地和国际会议上的报告传播。试验注册号:ChiCTR2500097067。
{"title":"Investigating the effect of transcranial magnetic stimulation combined with active sensory training on upper limb motor recovery after stroke: protocol for a randomised, sham-controlled, single-centre trial.","authors":"Yichen Jiang, Guangyue Zhu, Congcong Huo, Jinglei Wu, Wenxi Li, Mengchai Mao, Fan Hu, Jiayi Xia, Dongsheng Xu","doi":"10.1136/bmjopen-2025-102372","DOIUrl":"10.1136/bmjopen-2025-102372","url":null,"abstract":"<p><strong>Introduction: </strong>Transcranial magnetic stimulation (TMS) and upper extremity manipulation training have demonstrated clinical effectiveness in stroke rehabilitation. Post-stroke, the affected cerebral cortex often shows reduced excitability, which can limit the optimal outcomes of conventional manual training. To address this, we developed a new upper limb training method integrating TMS with active sensory training (AST) to enhance the fine motor ability in the upper limbs following stroke, potentially improving overall rehabilitation efficacy. However, the clinical effectiveness of this approach remains unclear. Importantly, we demonstrated the efficacy of the new rehabilitation strategy by using TMS in conjunction with AST in patients experiencing upper limb motor dysfunction after stroke.</p><p><strong>Methods and analysis: </strong>This single-centre, single-blind, sham stimulation, randomised controlled clinical trial investigated the efficacy of AST combined with TMS in patients with stroke and upper limb motor dysfunction post-stroke (1-24 months post-onset) at Brunnstrom stages III-V. Upper limb motor function was evaluated before and 2 weeks after the intervention. The primary outcome was the Action Research Arm Test result, and the secondary indicators included results on the Fugl-Meyer Assessment Upper Extremity Scale, Modified Barthel Index, Semmes-Weinstein Monofilament, Erasmus MC revised Nottingham Sensory Assessment Scale, Embodied Sense of Self Scale (stroke version), functional near-infrared spectroscopy and neuroelectrophysiology. Between-group differences were analysed using independent t-tests, and within-group differences were examined with paired t-tests, with statistical significance set at p<0.05.</p><p><strong>Ethics and dissemination: </strong>This study was approved by the Ethics Committee of the Second Rehabilitation Hospital of Shanghai for ethical application (Approval number: 2024-34-01). Written informed consent will be obtained from all participants. Study results will be disseminated through peer-reviewed journals and presentations at local and international conferences.</p><p><strong>Trial registration number: </strong>ChiCTR2500097067.</p>","PeriodicalId":9158,"journal":{"name":"BMJ Open","volume":"16 1","pages":"e102372"},"PeriodicalIF":2.3,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145965482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Specialist PrE-hospital rEDirection for ischaemic stroke thrombectomY (SPEEDY): study protocol for a cluster randomised controlled trial with included health economic and process evaluations. 专家院前重定向缺血性卒中血栓切除术(SPEEDY):纳入健康经济和过程评估的聚类随机对照试验的研究方案
IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-13 DOI: 10.1136/bmjopen-2025-112545
Lisa Shaw, Michael Allen, Jo Day, Gary A Ford, Martin James, Graham McClelland, Peter McMeekin, Helen Mossop, Catherine J Pope, Rosemary L Simmonds, Phil White, Nina Wilson, Christopher I Price
<p><strong>Background: </strong>Outcome from large vessel occlusion stroke can be significantly improved by time-critical thrombectomy but treatment is only available in regional comprehensive stroke centres (CSCs). Many patients are first admitted to a local primary stroke centre (PSC) and require transfer to a CSC, which delays treatment and decreases the chance of a good outcome. Access to thrombectomy might be improved if eligible patients could be identified in the prehospital setting and selectively redirected to a CSC. This study is evaluating a new specialist prehospital redirection pathway intended to facilitate access to thrombectomy.</p><p><strong>Methods and analysis: </strong>This study is a multicentre cluster randomised controlled trial with included health economic and process evaluations. Clusters are ambulance stations (or teams) which are work bases for ambulance practitioners. Intervention allocated ambulance practitioners use the Specialist PrE-hospital rEDirection for ischaemic stroke thrombectomY ('SPEEDY') pathway which comprises initiation according to specific criteria followed by contact with CSC staff who undertake a remote assessment to select patients for direct CSC admission. Control allocated ambulance practitioners continue to provide standard care which comprises admission to a local PSC and transfer to a CSC for thrombectomy if required. A co-primary outcome of thrombectomy treatment rate and time from stroke symptom onset to thrombectomy treatment will evaluate the impact of the pathway. Secondary outcomes include key aspects of emergency care including prehospital/hospital time intervals, receipt of other treatments including thrombolysis, and performance characteristics of the pathway. A broad population of all ambulance practitioner suspected and confirmed stroke patients across participating regions is being enrolled with a consent waiver. Data about SPEEDY pathway delivery are captured onto a study case record form, but all other data are obtained from routine healthcare records. Powered on a 'primary analysis population' (ischaemic stroke patients with pathway initiation criteria), 894 participants will detect an 8.4% difference in rate and data from 564 thrombectomy procedures will detect a 30 minute difference in time to treatment. The full study population is estimated to be approximately 80 000. Regression modelling will be used to examine primary and secondary outcomes in several analysis populations. The economic analyses will include cost-effectiveness and cost-utility analyses, and calculation of willingness to pay at a range of accepted threshold values. The process evaluation involves semi-structured interviews with professionals and patient/family members to explore views and experiences about the SPEEDY pathway.</p><p><strong>Ethics and dissemination: </strong>This study has ethical, Health Research Authority and participating NHS Trust approvals.Dissemination of study results will include pre
背景:大血管闭塞性卒中的预后可通过时间紧迫的血栓切除术显著改善,但治疗仅在区域性综合卒中中心(CSCs)可用。许多患者首先入住当地的原发性卒中中心(PSC),并需要转移到CSC,这延误了治疗并降低了良好预后的机会。如果可以在院前确定符合条件的患者并选择性地重新定向到CSC,则可以改善血栓切除术的使用。本研究正在评估一种新的专科院前重定向途径,旨在促进血栓切除术。方法和分析:本研究是一项多中心聚类随机对照试验,包括卫生经济和过程评估。集群是救护站(或救护队),是救护从业人员的工作基地。分配干预的救护车从业人员使用专门的院前再定向缺血性卒中血栓切除术(“SPEEDY”)途径,该途径包括根据特定标准启动,然后与CSC工作人员联系,后者进行远程评估,以选择直接CSC入院的患者。控制分配的救护车从业人员继续提供标准护理,包括入院到当地PSC和转移到CSC进行血栓切除术,如果需要的话。取栓治疗的发生率和从卒中症状出现到取栓治疗的时间的共同主要结局将评估该途径的影响。次要结局包括急诊护理的关键方面,包括院前/住院时间间隔、接受包括溶栓在内的其他治疗以及通路的表现特征。参与地区的所有救护车从业人员疑似和确诊中风患者的广泛人群正在接受同意豁免登记。关于快速途径递送的数据被捕获到研究病例记录表中,但所有其他数据都从常规医疗记录中获得。以“主要分析人群”(具有途径起始标准的缺血性卒中患者)为基础,894名参与者将检测到8.4%的发生率差异,564例取栓手术的数据将检测到30分钟的治疗时间差异。整个研究人群估计约为8万人。回归模型将用于检查几个分析人群的主要和次要结果。经济分析将包括成本效益和成本效用分析,以及在一系列可接受的阈值上计算支付意愿。过程评估包括与专业人员和患者/家属进行半结构化访谈,以探讨对SPEEDY途径的看法和经验。伦理和传播:本研究获得了伦理、健康研究权威和参与NHS信托的批准。研究结果的传播将包括在国内和国际会议和活动上的演讲,在同行评议的期刊上发表,以及为患者/公众参与活动提供简明的英语摘要。试验注册号:ISRCTN77453332。
{"title":"Specialist PrE-hospital rEDirection for ischaemic stroke thrombectomY (SPEEDY): study protocol for a cluster randomised controlled trial with included health economic and process evaluations.","authors":"Lisa Shaw, Michael Allen, Jo Day, Gary A Ford, Martin James, Graham McClelland, Peter McMeekin, Helen Mossop, Catherine J Pope, Rosemary L Simmonds, Phil White, Nina Wilson, Christopher I Price","doi":"10.1136/bmjopen-2025-112545","DOIUrl":"10.1136/bmjopen-2025-112545","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Outcome from large vessel occlusion stroke can be significantly improved by time-critical thrombectomy but treatment is only available in regional comprehensive stroke centres (CSCs). Many patients are first admitted to a local primary stroke centre (PSC) and require transfer to a CSC, which delays treatment and decreases the chance of a good outcome. Access to thrombectomy might be improved if eligible patients could be identified in the prehospital setting and selectively redirected to a CSC. This study is evaluating a new specialist prehospital redirection pathway intended to facilitate access to thrombectomy.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods and analysis: &lt;/strong&gt;This study is a multicentre cluster randomised controlled trial with included health economic and process evaluations. Clusters are ambulance stations (or teams) which are work bases for ambulance practitioners. Intervention allocated ambulance practitioners use the Specialist PrE-hospital rEDirection for ischaemic stroke thrombectomY ('SPEEDY') pathway which comprises initiation according to specific criteria followed by contact with CSC staff who undertake a remote assessment to select patients for direct CSC admission. Control allocated ambulance practitioners continue to provide standard care which comprises admission to a local PSC and transfer to a CSC for thrombectomy if required. A co-primary outcome of thrombectomy treatment rate and time from stroke symptom onset to thrombectomy treatment will evaluate the impact of the pathway. Secondary outcomes include key aspects of emergency care including prehospital/hospital time intervals, receipt of other treatments including thrombolysis, and performance characteristics of the pathway. A broad population of all ambulance practitioner suspected and confirmed stroke patients across participating regions is being enrolled with a consent waiver. Data about SPEEDY pathway delivery are captured onto a study case record form, but all other data are obtained from routine healthcare records. Powered on a 'primary analysis population' (ischaemic stroke patients with pathway initiation criteria), 894 participants will detect an 8.4% difference in rate and data from 564 thrombectomy procedures will detect a 30 minute difference in time to treatment. The full study population is estimated to be approximately 80 000. Regression modelling will be used to examine primary and secondary outcomes in several analysis populations. The economic analyses will include cost-effectiveness and cost-utility analyses, and calculation of willingness to pay at a range of accepted threshold values. The process evaluation involves semi-structured interviews with professionals and patient/family members to explore views and experiences about the SPEEDY pathway.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Ethics and dissemination: &lt;/strong&gt;This study has ethical, Health Research Authority and participating NHS Trust approvals.Dissemination of study results will include pre","PeriodicalId":9158,"journal":{"name":"BMJ Open","volume":"16 1","pages":"e112545"},"PeriodicalIF":2.3,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145964700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three decades of clinical trials in Portuguese-speaking Africa: a comprehensive scoping review protocol. 葡语非洲三十年临床试验:一项全面的范围审查方案。
IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-13 DOI: 10.1136/bmjopen-2025-105490
Jorge Pedro Barroso Batista, Maria Manuel Teixeira, Carla de Matos Torre, Bruno Sepodes, Ana Abecasis, Helder Mota-Filipe

Introduction: Published clinical trials offer valuable insights into the clinical research landscape in Portuguese-speaking African countries (PSAC)-Angola, Cabo Verde, Guinea-Bissau, São Tomé and Príncipe and Mozambique. The objective of this comprehensive scoping review is to systematically map and analyse randomised clinical trials (RCTs) evaluating pharmacological interventions conducted in PSAC from 1995 to 2024, in order to identify research trends, targeted diseases, geographic distribution and evidence gaps to better understand the development and evolution of clinical trials in the region. This is the first comprehensive scoping review to examine the clinical trials landscape in PSAC.

Methods and analysis: This scoping review adheres to the Joanna Briggs Institute methodology for scoping reviews, which builds on the Arksey and O'Malley methodological framework (refined by Levac et al) and will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews guidelines. A dual-search strategy will be used, consulting 4 electronic databases (MEDLINE, EMBASE, African Index Medicus, Cochrane Central Register of Clinical Trials) and 3 clinical trials registries platforms (Clinicaltrials.gov, International Clinical Trials Registry Platform, Pan African Clinical Trials Registry). Eligible studies will include RCTs conducted in at least one of the PSAC. Extracted data will include trial characteristics, targeted diseases, phases and designs, funding and ethical compliance. Risk of bias (RoB) will be assessed using the Cochrane RoB tool V.2.0 to evaluate the quality of the evidence included in the scoping review. Conclusions will be drawn upon the comparison between countries and their scope of clinical research, together with comparison with countries from other geographies, considering disease profiles.

Ethics and dissemination: Ethical approval is not required. Results will be disseminated through a peer-reviewed publication, conference presentation and in plain language in social media, both in Portuguese and in English.

Prospero registration number: This protocol is registered in the Open Science Framework https://osf.io/5nhc9.

已发表的临床试验为葡语非洲国家(PSAC)的临床研究前景提供了宝贵的见解,这些国家包括安哥拉、佛得角、几内亚比绍、和Príncipe以及莫桑比克。本综合范围综述的目的是系统地绘制和分析1995年至2024年在PSAC进行的评估药物干预的随机临床试验(rct),以确定研究趋势、靶向疾病、地理分布和证据差距,从而更好地了解该地区临床试验的发展和演变。这是第一个全面的范围审查,以检查临床试验的前景在PSAC。方法和分析:该范围评价遵循乔安娜布里格斯研究所的范围评价方法,该方法建立在Arksey和O'Malley方法框架(由Levac等人改进)的基础上,并将遵循系统评价的首选报告项目和范围评价的元分析扩展指南。将采用双检索策略,查阅4个电子数据库(MEDLINE、EMBASE、African Index Medicus、Cochrane Central Register of Clinical Trials)和3个临床试验注册平台(Clinicaltrials.gov、International Clinical Trials Registry Platform、Pan African Clinical Trials Registry)。符合条件的研究将包括在至少一个PSAC中进行的随机对照试验。提取的数据将包括试验特征、目标疾病、阶段和设计、资金和道德合规。偏倚风险(RoB)将使用Cochrane RoB工具V.2.0来评估纳入范围评价的证据的质量。将根据各国之间及其临床研究范围的比较,并考虑到疾病概况,与其他地区的国家进行比较,得出结论。伦理和传播:不需要伦理批准。研究结果将通过同行评议的出版物、会议报告以及葡萄牙语和英语两种通俗语言在社交媒体上传播。普洛斯彼罗注册号:该协议在开放科学框架https://osf.io/5nhc9中注册。
{"title":"Three decades of clinical trials in Portuguese-speaking Africa: a comprehensive scoping review protocol.","authors":"Jorge Pedro Barroso Batista, Maria Manuel Teixeira, Carla de Matos Torre, Bruno Sepodes, Ana Abecasis, Helder Mota-Filipe","doi":"10.1136/bmjopen-2025-105490","DOIUrl":"https://doi.org/10.1136/bmjopen-2025-105490","url":null,"abstract":"<p><strong>Introduction: </strong>Published clinical trials offer valuable insights into the clinical research landscape in Portuguese-speaking African countries (PSAC)-Angola, Cabo Verde, Guinea-Bissau, São Tomé and Príncipe and Mozambique. The objective of this comprehensive scoping review is to systematically map and analyse randomised clinical trials (RCTs) evaluating pharmacological interventions conducted in PSAC from 1995 to 2024, in order to identify research trends, targeted diseases, geographic distribution and evidence gaps to better understand the development and evolution of clinical trials in the region. This is the first comprehensive scoping review to examine the clinical trials landscape in PSAC.</p><p><strong>Methods and analysis: </strong>This scoping review adheres to the Joanna Briggs Institute methodology for scoping reviews, which builds on the Arksey and O'Malley methodological framework (refined by Levac <i>et al</i>) and will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews guidelines. A dual-search strategy will be used, consulting 4 electronic databases (MEDLINE, EMBASE, African Index Medicus, Cochrane Central Register of Clinical Trials) and 3 clinical trials registries platforms (Clinicaltrials.gov, International Clinical Trials Registry Platform, Pan African Clinical Trials Registry). Eligible studies will include RCTs conducted in at least one of the PSAC. Extracted data will include trial characteristics, targeted diseases, phases and designs, funding and ethical compliance. Risk of bias (RoB) will be assessed using the Cochrane RoB tool V.2.0 to evaluate the quality of the evidence included in the scoping review. Conclusions will be drawn upon the comparison between countries and their scope of clinical research, together with comparison with countries from other geographies, considering disease profiles.</p><p><strong>Ethics and dissemination: </strong>Ethical approval is not required. Results will be disseminated through a peer-reviewed publication, conference presentation and in plain language in social media, both in Portuguese and in English.</p><p><strong>Prospero registration number: </strong>This protocol is registered in the Open Science Framework https://osf.io/5nhc9.</p>","PeriodicalId":9158,"journal":{"name":"BMJ Open","volume":"16 1","pages":"e105490"},"PeriodicalIF":2.3,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145964946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coping outcomes among women living with infertility in Kumasi, Ghana: a qualitative study. 加纳库马西不孕妇女的应对结果:一项定性研究。
IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-13 DOI: 10.1136/bmjopen-2025-108118
Lydia Konadu, Josephine M Kyei, Florence Naab, Deborah Armah

Objectives: Women experiencing infertility employed various coping strategies to overcome the diverse stressors encountered. These coping strategies had their peculiar consequences or outcomes. This study aimed to explore the outcomes deduced from the coping strategies employed by women with infertility.

Design: The study employed a qualitative descriptive research design to gain an in-depth understanding of the outcomes of coping strategies used by women with infertility. In-depth interviews were conducted using a semi-structured interview guide.

Settings and participants: The study was carried out at a private fertility and specialist hospital within the Kumasi Metropolitan Assembly, where 15 women diagnosed with primary infertility were interviewed for 45 min to 1 hour each. With all participants completing the study, interviews were audiotaped with consent, transcribed verbatim and analysed using content analysis.

Results: The findings revealed that women with infertility used various coping strategies to mitigate the psychosocial stressors encountered. The coping strategies employed had a varying impact on the well-being of women with infertility, from long-term (physical health, mental health and life satisfaction) to short-term (composure and reduced state anxiety) coping outcomes. The result of the coping strategy employed had a varying impact on the well-being of women with infertility.

Conclusion: Women with infertility shared how they experienced good physical health, mental health and life satisfaction after employing adaptive coping strategies like seeking social support. They also shared how they exercised composure and had reduced state anxiety after using some maladaptive coping strategies, such as self-control and avoidance.

目的:不孕妇女采用不同的应对策略来克服所遇到的各种压力。这些应对策略有其特殊的后果或结果。本研究旨在探讨不孕妇女应对策略的结果。设计:本研究采用定性描述性研究设计,以深入了解不孕症妇女使用的应对策略的结果。深度访谈采用半结构化访谈指南进行。环境和参与者:该研究在库马西市议会内的一家私人生育和专科医院进行,在那里对15名被诊断为原发性不孕症的妇女进行了45分钟至1小时的访谈。在所有参与者完成研究后,在征得同意的情况下对访谈进行录音,逐字记录,并使用内容分析进行分析。结果:研究结果显示,不孕妇女使用各种应对策略来减轻所遇到的社会心理压力。所采用的应对策略对不孕妇女的健康有不同的影响,从长期(身体健康、心理健康和生活满意度)到短期(镇静和减少焦虑状态)的应对结果。所采用的应对策略的结果对不孕症妇女的福祉产生了不同的影响。结论:不孕症女性在采取寻求社会支持等适应性应对策略后,身体健康、心理健康和生活满意度均较好。他们还分享了在使用一些不适应的应对策略(如自我控制和回避)后,他们是如何保持镇静并减少状态焦虑的。
{"title":"Coping outcomes among women living with infertility in Kumasi, Ghana: a qualitative study.","authors":"Lydia Konadu, Josephine M Kyei, Florence Naab, Deborah Armah","doi":"10.1136/bmjopen-2025-108118","DOIUrl":"https://doi.org/10.1136/bmjopen-2025-108118","url":null,"abstract":"<p><strong>Objectives: </strong>Women experiencing infertility employed various coping strategies to overcome the diverse stressors encountered. These coping strategies had their peculiar consequences or outcomes. This study aimed to explore the outcomes deduced from the coping strategies employed by women with infertility.</p><p><strong>Design: </strong>The study employed a qualitative descriptive research design to gain an in-depth understanding of the outcomes of coping strategies used by women with infertility. In-depth interviews were conducted using a semi-structured interview guide.</p><p><strong>Settings and participants: </strong>The study was carried out at a private fertility and specialist hospital within the Kumasi Metropolitan Assembly, where 15 women diagnosed with primary infertility were interviewed for 45 min to 1 hour each. With all participants completing the study, interviews were audiotaped with consent, transcribed verbatim and analysed using content analysis.</p><p><strong>Results: </strong>The findings revealed that women with infertility used various coping strategies to mitigate the psychosocial stressors encountered. The coping strategies employed had a varying impact on the well-being of women with infertility, from long-term (physical health, mental health and life satisfaction) to short-term (composure and reduced state anxiety) coping outcomes. The result of the coping strategy employed had a varying impact on the well-being of women with infertility.</p><p><strong>Conclusion: </strong>Women with infertility shared how they experienced good physical health, mental health and life satisfaction after employing adaptive coping strategies like seeking social support. They also shared how they exercised composure and had reduced state anxiety after using some maladaptive coping strategies, such as self-control and avoidance.</p>","PeriodicalId":9158,"journal":{"name":"BMJ Open","volume":"16 1","pages":"e108118"},"PeriodicalIF":2.3,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145965330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Attitudes of maternity care providers toward regional centralisation of vaginal breech birth: a qualitative study. 产科护理提供者对阴道臀位分娩区域集中化的态度:一项定性研究。
IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-13 DOI: 10.1136/bmjopen-2025-110114
Danielle Luiting-Wagenaar, Merle van Dijk, Wessel Ganzevoort, Etelka Moll, Fedde Scheele, Joost Velzel

Objectives: To explore maternity care providers' attitudes toward regional centralisation of vaginal breech birth (VBB) care and gather their recommendations for maintaining clinical proficiency.

Design: Exploratory qualitative study using semi-structured interviews and thematic analysis.

Participants: 10 hospital-based maternity care professionals (nine obstetricians and one clinical midwife), purposively sampled to represent experience and institutional diversity.

Setting: 10 hospital maternity units in a metropolitan region of the Netherlands.Key themes describing provider attitudes towards two proposed models of centralised care (mobile breech team, designated referral centre) and alternative strategies.

Results: Three core themes emerged: (1) proficiency-providers valued regular exposure, formal training and peer support, expressing concern that centralisation would reduce overall workforce readiness; (2) organisation-concerns included unequal access, staffing burden, legal risks and inefficiencies in mobile teams and (3) alternatives-participants preferred a regional breech network with shared training, joint video review and expert on-call support.

Conclusions: Maternity care providers opposed full centralisation of VBB, favouring a networked model that distributes expertise and preserves local access. These insights highlight the importance of involving frontline providers in service redesign.

Trial registration number: Not applicable.

目的:探讨产科护理提供者对阴道分娩(VBB)区域集中护理的态度,并收集他们对保持临床熟练程度的建议。设计:探索性质的研究,采用半结构化访谈和专题分析。参与者:10名医院产科护理专业人员(9名产科医生和1名临床助产士),有意取样以代表经验和机构多样性。环境:在荷兰的一个大都市地区有10家医院产科。关键主题描述提供者对两种建议的集中护理模式的态度(移动分娩小组,指定转诊中心)和替代策略。结果:出现了三个核心主题:(1)熟练程度-供应商重视定期接触,正式培训和同伴支持,表达了对集中化会降低整体劳动力准备程度的担忧;(2)组织方面的担忧包括访问不平等、人员负担、法律风险和移动团队效率低下;(3)替代方案——参与者更倾向于一个具有共享培训、联合视频审查和专家随叫随到支持的区域网络。结论:产妇保健提供者反对完全集中的VBB,赞成网络模式,分配专业知识和保留本地访问。这些见解强调了让一线供应商参与服务重新设计的重要性。试验注册号:不适用。
{"title":"Attitudes of maternity care providers toward regional centralisation of vaginal breech birth: a qualitative study.","authors":"Danielle Luiting-Wagenaar, Merle van Dijk, Wessel Ganzevoort, Etelka Moll, Fedde Scheele, Joost Velzel","doi":"10.1136/bmjopen-2025-110114","DOIUrl":"https://doi.org/10.1136/bmjopen-2025-110114","url":null,"abstract":"<p><strong>Objectives: </strong>To explore maternity care providers' attitudes toward regional centralisation of vaginal breech birth (VBB) care and gather their recommendations for maintaining clinical proficiency.</p><p><strong>Design: </strong>Exploratory qualitative study using semi-structured interviews and thematic analysis.</p><p><strong>Participants: </strong>10 hospital-based maternity care professionals (nine obstetricians and one clinical midwife), purposively sampled to represent experience and institutional diversity.</p><p><strong>Setting: </strong>10 hospital maternity units in a metropolitan region of the Netherlands.Key themes describing provider attitudes towards two proposed models of centralised care (mobile breech team, designated referral centre) and alternative strategies.</p><p><strong>Results: </strong>Three core themes emerged: (1) proficiency-providers valued regular exposure, formal training and peer support, expressing concern that centralisation would reduce overall workforce readiness; (2) organisation-concerns included unequal access, staffing burden, legal risks and inefficiencies in mobile teams and (3) alternatives-participants preferred a regional breech network with shared training, joint video review and expert on-call support.</p><p><strong>Conclusions: </strong>Maternity care providers opposed full centralisation of VBB, favouring a networked model that distributes expertise and preserves local access. These insights highlight the importance of involving frontline providers in service redesign.</p><p><strong>Trial registration number: </strong>Not applicable.</p>","PeriodicalId":9158,"journal":{"name":"BMJ Open","volume":"16 1","pages":"e110114"},"PeriodicalIF":2.3,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145965403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global lifetime risk of developing myocarditis, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021. 全球罹患心肌炎的终生风险,1990-2021:来自2021年全球疾病负担研究的系统分析
IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-13 DOI: 10.1136/bmjopen-2025-105328
Chen Ji, Yuhao Li, Yuhao Wan, Zhikai Yang, Min Zeng, Ting Wang, Wenzheng Li, Junpeng Liu, Yingying Li, Shengfeng Wang, Hua Wang

Objectives: Age-standardised incidence rates of myocarditis have been widely reported; this metric primarily provides a cross-sectional view of risk based on a fixed standard population and does not capture the effects of population ageing. Lifetime risk represents the probability of developing myocarditis over an individual's lifespan and incorporates both demographic ageing and competing mortality, thereby offering a complementary perspective that reflects the burden experienced in real-world populations. This study aimed to estimate the global lifetime risk of myocarditis.

Design: This was a systematic analysis using publicly available aggregated data from Global Burden of Disease Study 2021.

Setting: The study included 204 countries and territories from 1990 to 2021.

Participants: We used deidentified data from the general population to measure the lifetime risk of developing myocarditis.

Primary and secondary outcome measures: The primary outcome was the estimated lifetime risk of developing myocarditis at the global, regional and national levels. Secondary outcomes included long-term trends in lifetime risk using the average annual percentage change (AAPC), variation in lifetime risk by age and sex, differences across Sociodemographic Index (SDI) levels assessed with concentration indices, and future risk estimated using an Autoregressive Integrated Moving Average (ARIMA) model.

Results: The global lifetime risk of developing myocarditis increased from 1.33% (95% CI 1.32% to 1.33%) in 1990 to 1.50% (95% CI 1.49% to 1.50%) in 2021 (AAPC: 0.388%, 95% CI 0.314% to 0.462%). High and high-middle SDI countries had the greatest risks. In 2021, risk was higher in males (1.59%, 95% CI 1.59% to 1.60%) than in females (1.40%, 95% CI 1.39% to 1.40%). People over 40 years, especially older women, had higher lifetime risks. Forecasts based on the ARIMA model suggest that the risk will continue to rise through 2050.

Conclusions: From 1990 to 2021, the global lifetime risk of developing myocarditis has shown an upward trend. It is crucial to enhance early detection and diagnostic capabilities in primary care settings.

目的:心肌炎的年龄标准化发病率已被广泛报道;这一指标主要提供了基于固定标准人口的风险的横截面视图,并没有捕捉到人口老龄化的影响。终生风险代表了个体一生中罹患心肌炎的概率,并结合了人口老龄化和竞争性死亡率,从而提供了一个反映现实世界人群所经历的负担的补充观点。本研究旨在估计全球一生罹患心肌炎的风险。设计:这是一项系统分析,使用了《2021年全球疾病负担研究》中可公开获得的汇总数据。环境:该研究包括1990年至2021年期间的204个国家和地区。参与者:我们使用来自普通人群的未识别数据来测量患心肌炎的终生风险。主要结局指标和次要结局指标:主要结局指标是全球、地区和国家水平上患心肌炎的估计终生风险。次要结局包括使用平均年百分比变化(AAPC)的终身风险长期趋势,年龄和性别的终身风险变化,使用浓度指数评估的社会人口指数(SDI)水平的差异,以及使用自回归综合移动平均(ARIMA)模型估计的未来风险。结果:罹患心肌炎的全球终生风险从1990年的1.33% (95% CI 1.32% ~ 1.33%)增加到2021年的1.50% (95% CI 1.49% ~ 1.50%) (AAPC: 0.388%, 95% CI 0.314% ~ 0.462%)。高和中高SDI国家的风险最大。2021年,男性的风险(1.59%,95% CI 1.59%至1.60%)高于女性(1.40%,95% CI 1.39%至1.40%)。40岁以上的人,尤其是老年妇女,终生风险更高。基于ARIMA模型的预测表明,到2050年,这种风险将继续上升。结论:从1990年到2021年,全球罹患心肌炎的终生风险呈上升趋势。加强初级保健机构的早期发现和诊断能力至关重要。
{"title":"Global lifetime risk of developing myocarditis, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.","authors":"Chen Ji, Yuhao Li, Yuhao Wan, Zhikai Yang, Min Zeng, Ting Wang, Wenzheng Li, Junpeng Liu, Yingying Li, Shengfeng Wang, Hua Wang","doi":"10.1136/bmjopen-2025-105328","DOIUrl":"https://doi.org/10.1136/bmjopen-2025-105328","url":null,"abstract":"<p><strong>Objectives: </strong>Age-standardised incidence rates of myocarditis have been widely reported; this metric primarily provides a cross-sectional view of risk based on a fixed standard population and does not capture the effects of population ageing. Lifetime risk represents the probability of developing myocarditis over an individual's lifespan and incorporates both demographic ageing and competing mortality, thereby offering a complementary perspective that reflects the burden experienced in real-world populations. This study aimed to estimate the global lifetime risk of myocarditis.</p><p><strong>Design: </strong>This was a systematic analysis using publicly available aggregated data from Global Burden of Disease Study 2021.</p><p><strong>Setting: </strong>The study included 204 countries and territories from 1990 to 2021.</p><p><strong>Participants: </strong>We used deidentified data from the general population to measure the lifetime risk of developing myocarditis.</p><p><strong>Primary and secondary outcome measures: </strong>The primary outcome was the estimated lifetime risk of developing myocarditis at the global, regional and national levels. Secondary outcomes included long-term trends in lifetime risk using the average annual percentage change (AAPC), variation in lifetime risk by age and sex, differences across Sociodemographic Index (SDI) levels assessed with concentration indices, and future risk estimated using an Autoregressive Integrated Moving Average (ARIMA) model.</p><p><strong>Results: </strong>The global lifetime risk of developing myocarditis increased from 1.33% (95% CI 1.32% to 1.33%) in 1990 to 1.50% (95% CI 1.49% to 1.50%) in 2021 (AAPC: 0.388%, 95% CI 0.314% to 0.462%). High and high-middle SDI countries had the greatest risks. In 2021, risk was higher in males (1.59%, 95% CI 1.59% to 1.60%) than in females (1.40%, 95% CI 1.39% to 1.40%). People over 40 years, especially older women, had higher lifetime risks. Forecasts based on the ARIMA model suggest that the risk will continue to rise through 2050.</p><p><strong>Conclusions: </strong>From 1990 to 2021, the global lifetime risk of developing myocarditis has shown an upward trend. It is crucial to enhance early detection and diagnostic capabilities in primary care settings.</p>","PeriodicalId":9158,"journal":{"name":"BMJ Open","volume":"16 1","pages":"e105328"},"PeriodicalIF":2.3,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145965368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Data-driven strategies for model-informed decision-making during the COVID-19 pandemic: a systematic review. 2019冠状病毒病大流行期间基于模型的决策的数据驱动战略:系统回顾
IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-13 DOI: 10.1136/bmjopen-2025-107660
Mehdi Lotfi, Lars Kaderali

Objectives: To systematically review data-driven modelling studies that evaluated the effectiveness of interventions implemented during the COVID-19 pandemic and to identify which measures were most frequently reported as effective in controlling disease spread.

Design: Systematic review of modelling studies focused on data-driven, model-informed decision-making for COVID-19 interventions.

Data sources: A comprehensive literature search was conducted in PubMed, Web of Science and Embase, covering publications from 1 January 2020 to 16 October 2024.

Eligibility criteria: Studies were included if they: (1) used real-world data; (2) had sufficient sample sizes and (3) assessed at least one intervention with measurable outcomes.Meta-analyses and purely theoretical modelling studies were excluded. Papers were further filtered using a structured screening process to ensure empirical and intervention-based modelling.

Data extraction and synthesis: Data were extracted from eligible studies and categorised according to modelling approaches, data sources, intervention types and reported effectiveness. Descriptive synthesis was performed to summarise modelling trends and intervention performance. Studies were classified into major intervention categories, including tracing, testing and isolation (TTI); physical and social distancing (PSD); vaccination; lockdowns; mask-wearing; home office or stay-at-home (HOSH) and health infrastructure enhancement (HIE).

Results: Out of 2297 studies identified, 126 met inclusion criteria. Compartmental models were the most frequently used approach, primarily relying on case and death counts to assess intervention impact. The most commonly reported effective interventions were TTI, PSD, vaccination, lockdowns, mask-wearing and HOSH. When considering effectiveness relative to study frequency, the top six interventions were TTI, HOSH, mask-wearing, HIE, PSD and lockdowns. The relatively lower representation of vaccination reflects that most included studies were conducted during the early stages of the pandemic, before widespread vaccine rollout and availability of empirical vaccination data.

Conclusions: This review highlights the critical role of data-driven models in guiding COVID-19 response strategies. Evidence supports the combined effectiveness of non-pharmaceutical interventions, robust testing and tracing systems and health infrastructure strengthening. Real-world impact, however, remains dependent on local healthcare capacity, socioeconomic conditions and cultural contexts. Continued research is essential to refine adaptive modelling approaches and strengthen preparedness for future public health emergencies.

目的:系统回顾评估COVID-19大流行期间实施的干预措施有效性的数据驱动建模研究,并确定哪些措施在控制疾病传播方面最常被报告为有效。设计:系统回顾建模研究,重点关注COVID-19干预措施的数据驱动、模型知情决策。数据来源:在PubMed、Web of Science和Embase中进行了全面的文献检索,涵盖了2020年1月1日至2024年10月16日的出版物。入选标准:如果研究:(1)使用真实数据;(2)有足够的样本量,(3)评估了至少一项具有可测量结果的干预措施。荟萃分析和纯理论模型研究被排除在外。论文使用结构化筛选过程进一步筛选,以确保实证和基于干预的建模。数据提取和综合:从符合条件的研究中提取数据,并根据建模方法、数据来源、干预类型和报告的有效性进行分类。进行描述性综合以总结建模趋势和干预效果。研究分为主要干预类别,包括追踪、检测和隔离(TTI);保持身体和社会距离;疫苗接种;锁定;戴面罩;家庭办公或居家(HOSH)和卫生基础设施改善(HIE)。结果:在2297项研究中,126项符合纳入标准。分区模型是最常用的方法,主要依靠病例数和死亡人数来评估干预措施的影响。最常见的有效干预措施是TTI、PSD、疫苗接种、封锁、戴口罩和卫生保健。当考虑与学习频率相关的有效性时,排名前六的干预措施是TTI、HOSH、戴口罩、HIE、PSD和封锁。疫苗接种的代表性相对较低,这反映了大多数纳入的研究是在大流行的早期阶段进行的,当时还没有广泛推广疫苗和获得经验疫苗接种数据。结论:本综述强调了数据驱动模型在指导COVID-19应对战略方面的关键作用。证据支持非药物干预措施、强有力的检测和追踪系统以及加强卫生基础设施的综合效果。然而,现实世界的影响仍然取决于当地的医疗保健能力、社会经济条件和文化背景。持续的研究对于改进适应性建模方法和加强对未来突发公共卫生事件的准备至关重要。
{"title":"Data-driven strategies for model-informed decision-making during the COVID-19 pandemic: a systematic review.","authors":"Mehdi Lotfi, Lars Kaderali","doi":"10.1136/bmjopen-2025-107660","DOIUrl":"https://doi.org/10.1136/bmjopen-2025-107660","url":null,"abstract":"<p><strong>Objectives: </strong>To systematically review data-driven modelling studies that evaluated the effectiveness of interventions implemented during the COVID-19 pandemic and to identify which measures were most frequently reported as effective in controlling disease spread.</p><p><strong>Design: </strong>Systematic review of modelling studies focused on data-driven, model-informed decision-making for COVID-19 interventions.</p><p><strong>Data sources: </strong>A comprehensive literature search was conducted in PubMed, Web of Science and Embase, covering publications from 1 January 2020 to 16 October 2024.</p><p><strong>Eligibility criteria: </strong>Studies were included if they: (1) used real-world data; (2) had sufficient sample sizes and (3) assessed at least one intervention with measurable outcomes.Meta-analyses and purely theoretical modelling studies were excluded. Papers were further filtered using a structured screening process to ensure empirical and intervention-based modelling.</p><p><strong>Data extraction and synthesis: </strong>Data were extracted from eligible studies and categorised according to modelling approaches, data sources, intervention types and reported effectiveness. Descriptive synthesis was performed to summarise modelling trends and intervention performance. Studies were classified into major intervention categories, including tracing, testing and isolation (TTI); physical and social distancing (PSD); vaccination; lockdowns; mask-wearing; home office or stay-at-home (HOSH) and health infrastructure enhancement (HIE).</p><p><strong>Results: </strong>Out of 2297 studies identified, 126 met inclusion criteria. Compartmental models were the most frequently used approach, primarily relying on case and death counts to assess intervention impact. The most commonly reported effective interventions were TTI, PSD, vaccination, lockdowns, mask-wearing and HOSH. When considering effectiveness relative to study frequency, the top six interventions were TTI, HOSH, mask-wearing, HIE, PSD and lockdowns. The relatively lower representation of vaccination reflects that most included studies were conducted during the early stages of the pandemic, before widespread vaccine rollout and availability of empirical vaccination data.</p><p><strong>Conclusions: </strong>This review highlights the critical role of data-driven models in guiding COVID-19 response strategies. Evidence supports the combined effectiveness of non-pharmaceutical interventions, robust testing and tracing systems and health infrastructure strengthening. Real-world impact, however, remains dependent on local healthcare capacity, socioeconomic conditions and cultural contexts. Continued research is essential to refine adaptive modelling approaches and strengthen preparedness for future public health emergencies.</p>","PeriodicalId":9158,"journal":{"name":"BMJ Open","volume":"16 1","pages":"e107660"},"PeriodicalIF":2.3,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145965373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMJ Open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1